ERBB2 and breast carcinoma: Compared with previous studies, this is the first network-analyzed WGCNA approach with full thought of high-throughput data including the training dataset of 310 HER2-negative breast cancer samples received taxane-anthracycline treatment and an independent validation set with 198 samples to confirm the relations of the gene modules or hub genes.